Applications: Importer of Controlled Substances

Federal Register: June 28, 2010 (Volume 75, Number 123)

Notices

Page 36680

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr28jn10-95

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances; Notice of Application

This is notice that on March 31, 2010, Rhodes Technologies, 498

Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II:

Drug

Schedule

Raw Opium (9600)........................... II

Concentrate of Poppy Straw (9670).......... II

The company imports the listed controlled substances in order to bulk manufacture controlled substances in Active Pharmaceutical

Ingredient (API) form. The company distributes the manufactured APIs in bulk form only to its customers.

As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate.

As noted in a previous notice published in the Federal Register on

September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy

Assistant Administrator, Office of Diversion Control, Drug Enforcement

Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b),(c),(d),(e), and (f) are satisfied.

Dated: June 17, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug

Enforcement Administration.

FR Doc. 2010-15522 Filed 6-25-10; 8:45 am

BILLING CODE 4410-09-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT